Summary
- Current Price
- As of today, KYTX price is $6.80, down -0.58% on
- Current Price All-Time High
- KYTX price is currently -77.78% below its historical high of $30.60 set on
- Market Cap
- KYTX current market cap is $421M, up +60.04% over the past 365 days
- Revenue
- KYTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for KYTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Kyverna Therapeutics, Inc. |
| Ticker | NASDAQ: KYTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kyvernatx.com |
| Employees | 119 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $6.80 | |
| Price, 1D Change | -0.58% | |
| $421M | ||
| - | ||
| - | ||
| 2.46 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.64 | ||
| EPS, 1Y Change | -9.60% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.64 | ||
| EPS Estimate | -$2.77 | N/A |
| EPS Est. Change | +24.01% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $6.80 | |
| Price Target | $32.00 | - |
| Price Tgt. Change | +370.59% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.28 | -$3.33 | -1.42% | |
| -$3.70 | -$3.64 | +1.38% | |
| -$2.77 | N/A | +24.01% | |
| -$3.17 | N/A | +13.04% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $17.20M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $6.80 | |
| $8.39 | ||
| $7.75 | ||
| $7.85 | ||
| $7.69 | ||
| -$0.33 | ||
| 2.46 | ||
| $0.44 | ||
| 37.06 | ||
| 46.86% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.64 | ||
| -$1.80M | ||
| - | ||
| -$169.18M | ||
| - | ||
| -$161.31M | ||
| - | ||
| -$167.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.13 | ||
| 7.75 | ||
| 7.75 | ||
| - | ||
| - | ||
| 1.12 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.54 | ||
| -1.61 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $232.28M | ||
| $279.25M | ||
| $294.95M | ||
| $282.95M | ||
| $62.68M | ||
| $36.49M | ||
| $29.03M | ||
| $3.97M | ||
| $5.31M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $161.31M | ||
| $167.38M | ||
| $1.80M | ||
| $0.00 | ||
| $1.80M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$153.71M | ||
| $40.02M | ||
| $141.17M | ||
| $1.13M | ||
| -$154.85M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with KYTX
FAQ
- What is the ticker symbol for Kyverna Therapeutics, Inc.?
- The ticker symbol for Kyverna Therapeutics, Inc. is NASDAQ:KYTX
- Does Kyverna Therapeutics, Inc. pay dividends?
- No, Kyverna Therapeutics, Inc. does not pay dividends
- What sector is Kyverna Therapeutics, Inc. in?
- Kyverna Therapeutics, Inc. is in the Healthcare sector
- What industry is Kyverna Therapeutics, Inc. in?
- Kyverna Therapeutics, Inc. is in the Biotechnology industry
- What country is Kyverna Therapeutics, Inc. based in?
- Kyverna Therapeutics, Inc. is headquartered in United States
- When did Kyverna Therapeutics, Inc. go public?
- Kyverna Therapeutics, Inc. initial public offering (IPO) was on February 9, 2024
- Is Kyverna Therapeutics, Inc. in the S&P 500?
- No, Kyverna Therapeutics, Inc. is not included in the S&P 500 index
- Is Kyverna Therapeutics, Inc. in the NASDAQ 100?
- No, Kyverna Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Kyverna Therapeutics, Inc. in the Dow Jones?
- No, Kyverna Therapeutics, Inc. is not included in the Dow Jones index
- When was Kyverna Therapeutics, Inc. last earnings report?
- Kyverna Therapeutics, Inc.'s most recent earnings report was on August 11, 2026
- When does Kyverna Therapeutics, Inc. report earnings?
- The next expected earnings date for Kyverna Therapeutics, Inc. is November 11, 2026
Data Sources & References
- KYTX Official Website kyvernatx.com
- KYTX Profile on Yahoo Finance finance.yahoo.com/quote/KYTX
- KYTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kytx